DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $649,795,982 | +3.3% | 2,619,089 | -0.1% | 0.42% | +25.7% |
| Q2 2023 | $629,082,240 | +6.3% | 2,621,176 | +11.7% | 0.33% | +1.5% |
| Q1 2023 | $591,688,600 | -5.9% | 2,347,598 | -0.9% | 0.33% | -9.1% |
| Q4 2022 | $628,981,702 | +7.3% | 2,369,760 | +4.4% | 0.36% | +2.3% |
| Q3 2022 | $586,321,000 | +13.2% | 2,270,007 | +11.1% | 0.35% | +22.5% |
| Q2 2022 | $518,111,000 | -21.0% | 2,043,664 | -8.6% | 0.29% | -5.6% |
| Q1 2022 | $655,682,000 | +10.3% | 2,235,309 | +23.7% | 0.31% | +14.6% |
| Q4 2021 | $594,294,000 | +11.0% | 1,806,312 | +2.7% | 0.27% | +5.1% |
| Q3 2021 | $535,321,000 | +30.8% | 1,758,375 | +15.3% | 0.25% | +27.6% |
| Q2 2021 | $409,270,000 | +21.4% | 1,525,078 | +1.8% | 0.20% | +9.3% |
| Q1 2021 | $337,237,000 | +3.6% | 1,498,283 | +2.3% | 0.18% | -8.5% |
| Q4 2020 | $325,405,000 | +3.1% | 1,464,860 | -0.1% | 0.20% | -8.3% |
| Q3 2020 | $315,655,000 | +2.3% | 1,465,917 | -16.0% | 0.22% | -7.7% |
| Q2 2020 | $308,568,000 | +67.9% | 1,744,995 | +31.4% | 0.24% | +43.3% |
| Q1 2020 | $183,797,000 | -36.4% | 1,327,918 | -29.4% | 0.16% | -12.8% |
| Q4 2019 | $288,811,000 | +10.8% | 1,881,820 | +4.2% | 0.19% | +3.9% |
| Q3 2019 | $260,719,000 | -18.0% | 1,805,227 | -18.9% | 0.18% | -3.2% |
| Q2 2019 | $317,955,000 | +11.1% | 2,224,769 | +2.6% | 0.19% | +10.0% |
| Q1 2019 | $286,260,000 | +38.1% | 2,168,378 | +7.9% | 0.17% | +15.6% |
| Q4 2018 | $207,274,000 | -71.7% | 2,010,124 | -70.2% | 0.15% | -31.3% |
| Q3 2018 | $732,907,000 | +63.1% | 6,745,025 | +48.1% | 0.21% | +67.2% |
| Q2 2018 | $449,469,000 | +80.7% | 4,554,878 | +79.3% | 0.13% | +7.6% |
| Q1 2018 | $248,739,000 | +27.8% | 2,540,591 | +21.2% | 0.12% | -4.0% |
| Q4 2017 | $194,625,000 | +33.4% | 2,096,892 | +23.2% | 0.12% | +24.0% |
| Q3 2017 | $145,935,000 | -15.9% | 1,701,352 | -17.3% | 0.10% | -19.4% |
| Q2 2017 | $173,599,000 | -0.1% | 2,057,194 | +1.3% | 0.12% | -3.1% |
| Q1 2017 | $173,707,000 | +3.8% | 2,031,029 | -5.5% | 0.13% | -4.5% |
| Q4 2016 | $167,331,000 | -21.7% | 2,149,802 | -21.2% | 0.13% | -11.3% |
| Q3 2016 | $213,754,000 | -10.6% | 2,726,913 | +15.2% | 0.15% | -10.7% |
| Q2 2016 | $238,994,000 | -11.4% | 2,366,359 | -16.8% | 0.17% | -16.7% |
| Q1 2016 | $269,755,000 | +22.8% | 2,843,782 | +20.3% | 0.20% | +33.6% |
| Q4 2015 | $219,610,000 | +28.9% | 2,364,522 | +18.3% | 0.15% | +15.2% |
| Q3 2015 | $170,317,000 | -15.7% | 1,998,856 | -15.3% | 0.13% | +2.3% |
| Q2 2015 | $202,006,000 | -1.5% | 2,360,243 | -2.3% | 0.13% | +0.8% |
| Q1 2015 | $205,115,000 | +4.3% | 2,416,009 | +5.3% | 0.13% | +5.8% |
| Q4 2014 | $196,619,000 | +0.2% | 2,294,057 | -11.2% | 0.12% | -0.8% |
| Q3 2014 | $196,310,000 | -9.7% | 2,583,778 | -6.4% | 0.12% | -17.6% |
| Q2 2014 | $217,323,000 | -5.7% | 2,760,431 | -10.2% | 0.15% | -9.8% |
| Q1 2014 | $230,547,000 | -1.5% | 3,074,585 | +1.3% | 0.16% | -2.4% |
| Q4 2013 | $234,003,000 | +8.1% | 3,035,920 | -2.8% | 0.17% | +5.0% |
| Q3 2013 | $216,517,000 | – | 3,124,495 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |